RECORD // Company
Silence Therapeutics plc
Built 2026-11-22T03:28:07Z from public sources · JSON · Open the company profile
ASK THE RECORDS
Ask
COMPANY
Records for this company (1 joined by official identifier)
Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.
SEC EDGAR (1)
- Silence Therapeutics plc · the SEC registrant record of this company
Matched by name only, not merged (3)
These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).
- Silence Therapeutics GmbH · Ctgov · name equals 'Silence Therapeutics' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
- Silence Therapeutics plc · Ctgov · same registered legal name as 'Silence Therapeutics plc' Possible match based on name, not a shared identifier. Compare the records. Compare
- SILENCE THERAPEUTICS, INC. · Ny corps · name equals 'Silence Therapeutics' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
6 VALUES · 10-Q · EACH LINKS TO ITS FILING
Latest quarter
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-13 · accession 0001193125-26-458896
| Item | Value | Period | Form | Filed | Accession | Report | |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | 3 months ended 2026-09-30 | 10-Q | 2026-11-13 | 0001193125-26-458896 | 2026-11-22 03:28 UTC | Report an error |
| Net income (loss) | $-12,426,000 | 3 months ended 2026-09-30 | 10-Q | 2026-11-13 | 0001193125-26-458896 | 2026-11-22 03:28 UTC | Report an error |
| Cash and cash equivalents | $247,659,000 | at 2026-09-30 | 10-Q | 2026-11-13 | 0001193125-26-458896 | 2026-11-22 03:28 UTC | Report an error |
| Contract liabilities (total) | $55,218,000 | at 2026-09-30 | 10-Q | 2026-11-13 | 0001193125-26-458896 | 2026-11-22 03:28 UTC | Report an error |
| Contract liabilities, current | $0 | at 2026-09-30 | 10-Q | 2026-11-13 | 0001193125-26-458896 | 2026-11-22 03:28 UTC | Report an error |
| Contract liabilities, noncurrent | $55,218,000 | at 2026-09-30 | 10-Q | 2026-11-13 | 0001193125-26-458896 | 2026-11-22 03:28 UTC | Report an error |
Negative as reported in the filing.
Not in this report's XBRL: Interest expense.
Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.
IDS
Identifiers
- SEC CIK
- 0001479615
- Ticker
- SLN
- CUSIP
- G8128Y157
- Record ID
- sx:sec:0001479615
OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA
Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
18 FACTS · EACH LINKS TO ITS FILING
Facts
| Fact | Value | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-16 | SEC EDGAR company profile | 2026-11-22 03:28 UTC | Report an error |
| SIC industry | 2834 Pharmaceutical Preparations | 2026-11-16 | SEC EDGAR company profile | 2026-11-22 03:28 UTC | Report an error |
| State of incorporation | X0 | 2026-11-16 | SEC EDGAR company profile | 2026-11-22 03:28 UTC | Report an error |
| Business address | 12 HAMMERSMITH GROVE, OFFICE 205, LONDON, W6 7AP | 2026-11-16 | SEC EDGAR company profile | 2026-11-22 03:28 UTC | Report an error |
| Exchanges | Nasdaq, OTC | 2026-11-16 | SEC EDGAR company profile | 2026-11-22 03:28 UTC | Report an error |
| Revenue (fiscal year ended 2025-12-31) | $559,000 | 2025-12-31 | 10-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax | 2026-11-22 03:28 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-12-31) | $-88,612,000 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | 2026-11-22 03:28 UTC | Report an error |
| Total assets (at 2025-12-31) | $131,442,000 | 2025-12-31 | 10-K, XBRL Assets | 2026-11-22 03:28 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $62,304,000 | 2025-12-31 | 10-K, XBRL StockholdersEquity | 2026-11-22 03:28 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $11,277,000 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | 2026-11-22 03:28 UTC | Report an error |
| Operating cash flow (fiscal year ended 2025-12-31) | $-62,271,000 | 2025-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | 2026-11-22 03:28 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31) | $55,000 | 2025-12-31 | 10-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment | 2026-11-22 03:28 UTC | Report an error |
| Operating lease liabilities (at 2025-12-31) | $160,000 | 2025-12-31 | 10-K, XBRL OperatingLeaseLiability | 2026-11-22 03:28 UTC | Report an error |
| Form D total offering amount (D filed 2021-02-18) | $45,499,905 | 2021-02-18 | D | 2026-11-22 03:28 UTC | Report an error |
| Form D total amount sold (D filed 2021-02-18) | $45,499,905 | 2021-02-18 | D | 2026-11-22 03:28 UTC | Report an error |
| Form D industry group | Biotechnology | 2021-02-18 | D | 2026-11-22 03:28 UTC | Report an error |
| Form D revenue range | Decline to Disclose | 2021-02-18 | D | 2026-11-22 03:28 UTC | Report an error |
| Form D date of first sale | 2021-02-04 | 2021-02-18 | D | 2026-11-22 03:28 UTC | Report an error |
EVERY DATED RECORD, NEWEST FIRST
Timeline
- 2026-11-13 Filing 10-Q filed
- 2026-11-12 Filing DEFA14A filed
- 2026-11-12 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-10-19 Filing DEFA14A filed
- 2026-10-19 Filing DEFA14A filed
- 2026-10-19 Filing 8-K filed: Item 1.01 material agreement; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-08-12 Filing 8-K filed: Item 1.01 material agreement; Item 8.01 other event; Item 9.01 exhibits
- 2026-08-12 Filing 424B5 filed
- 2026-08-11 Filing S-3MEF filed
- 2026-08-10 Filing 424B5 filed
- 2026-08-10 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 8.01 other event; Item 9.01 exhibits
- 2026-08-10 Filing 10-Q filed
- 2026-08-10 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-07-16 Filing 8-K/A filed: Item 5.02 officer or director change
- 2026-06-23 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-06-16 Filing 8-K filed: Item 5.07 shareholder vote
- 2026-06-11 Filing 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2026-05-27 Filing EFFECT filed
- 2026-05-27 Filing 424B5 filed
- 2026-05-22 Filing CORRESP filed
- 2026-05-22 Filing UPLOAD filed
- 2026-05-18 Filing 8-K filed: Item 1.01 material agreement; Item 1.02 agreement terminated; Item 8.01 other event; Item 9.01 exhibits
- 2026-05-18 Filing S-3 filed
- 2026-05-07 Filing 10-Q filed
- 2026-05-07 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
WHAT IS NOT HERE
Gaps
- Court records: not covered yet (expected 11-19).
- No EIN on the SEC filing, so no Form 990 lookup
- SEC 13F holders: no 13F holdings for this CUSIP in period 2026-06-30
- USAspending: no recipient whose SAM legal name and address match this SEC filer
SOURCES AND LICENSE
Sources
- SEC EDGAR: checked · 2026-11-22T03:28:07Z
- Propublica 990: checked, nothing found · 2026-11-22T03:28:08Z
- SEC 13F holdings: checked · 2026-11-22T03:28:08Z
- USAspending: checked, nothing found · 2026-11-22T03:28:09Z
CC BY 4.0 -- credit Seraphix Systems.
API
Use this record
Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.